使用自动化平台 Lustro 在酵母中进行高通量光遗传学实验
August 4th, 2023
1.3K views
该协议概述了利用自动化平台Lustro对酵母中的光遗传学系统进行高通量表征的步骤。
目前有不同的设备，如生物反应器和微孔板照明器。生物反应器提供良好的时间分辨率，但通量有限。微孔板设备提供更高的通量，但缺乏自动化，无法随时间推移可靠地记录输出。
Lustro 为光遗传学系统提供可靠和高通量的实时表征。它还可以与液处理机器人可以执行的检测连接。光遗传学系统是一种有吸引力的工具，因为它们对细胞行为提供了精细的空间和时间控制。
更快地设计、构建和测试光遗传学系统的能力将为更好地理解和控制生物行为铺平道路。
View the full transcript and gain access to thousands of scientific videos
概览
本协议概述了使用自动化平台Lustro来对酵母中的光遗传学系统进行高通量表征的步骤。Lustro提供实时可靠和高效的表征，并与液体处理机器人接口以实现更高程度的自动化。
关键研究组成部分
科学领域
- 光遗传学
- 高通量筛选
- 酵母模型系统
背景
- 光遗传学系统允许对细胞行为进行精确控制。
- 当前设备包括生物反应器和微孔板照明器。
- 生物反应器提供精细的时间分辨率，但吞吐量有限。
- 微孔板设备提供更高的吞吐量，但缺乏自动化。
研究目的
- 利用Lustro进行光遗传学系统的高通量表征。
- 改进随时间记录输出的自动化。
- 提高液体处理机器人执行的测定效率。
使用的方法
- 利用Lustro平台进行表征。
- 与液体处理机器人集成以实现测定自动化。
- 对光遗传学系统进行实时监控。
- 与传统的生物反应器和微孔板方法进行比较。
主要结果
- Lustro提供了光遗传学系统的可靠表征。
- 高通量能力超过传统方法。
- 实时数据记录提高了实验准确性。
- 自动化减少了人工干预和错误。
结论
- Lustro是进行高通量光遗传学研究的有效工具。
- 自动化显著改进了实验工作流程。
- 未来应用可能扩展到其他生物系统。
常见问题
什么是Lustro？
Lustro是一个用于光遗传学系统高通量表征的自动化平台。
Lustro与传统方法相比如何？
Lustro提供更高的吞吐量和实时监控，使其比传统的生物反应器和微孔板设备更加高效。
Lustro可以与其他实验室设备接口吗？
是的，Lustro可以与液体处理机器人接口以实现测定自动化。
使用光遗传学系统的优势是什么？
光遗传学系统提供对细胞行为精细的空间和时间控制，允许进行精确的实验操作。
该协议是否适用于其他生物体？
虽然该协议专注于酵母，但原理可能被适应用于其他生物系统。
Executive Industry Relevance
High-throughput optogenetics in yeast, enabled by the Lustro platform, addresses the bottleneck of iterative design-build-test cycles in synthetic biology and gene circuit engineering. By automating light stimulation and quantitative readouts, Lustro enhances predictive confidence and accelerates early discovery inflection points for programmable cell systems. This capability supports portfolio-wide evaluation of optogenetic constructs, reducing cycle time and resource intensity in R&D pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rapid interrogation of gene circuit function under controlled light conditions.
- Supports biological de-risking by quantifying optogenetic response dynamics across multiple constructs.
- Facilitates functional target validation through precise, programmable stimulation and measurement.
- Improves predictive confidence for advancing synthetic biology assets.
Screening & Assay Development
- Automates preparation and stimulation of yeast strains for standardized, reproducible assays.
- Delivers high-throughput, quantitative fluorescence and growth measurements for robust screening.
- Enables scalable evaluation of optogenetic system parameters such as duty cycle and intensity.
- Supports reliable compound or construct assessment in multiplexed formats.
Translational & Preclinical Research
- Aligns optogenetic system performance with disease-relevant cellular behaviors when applicable.
- Provides continuity from discovery to preclinical validation for programmable gene expression systems.
- Reduces mechanistic ambiguity by linking light input to quantitative phenotypic outputs.
Pipeline & Workflow Integration
Lustro integrates into the discovery-to-lead identification continuum by automating optogenetic system characterization and enabling data-driven construct selection for downstream development.
- Discovery Biology: Supports hypothesis testing and pathway clarification via programmable light stimulation and real-time measurement.
- Screening: Delivers assay-ready, reproducible, and quantitative outputs for construct triage.
- Analytics: Provides time-resolved fluorescence and growth data to compare optogenetic responses across conditions.
- Translational Research: Facilitates continuity for programmable systems advancing toward preclinical models.
- Enterprise Reuse: Establishes a reusable automation platform for iterative synthetic biology workflows.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic uncertainty in optogenetic system development.
- Operational Value: Standardizes and scales optogenetic assays, minimizing manual intervention and error.
- Strategic Value: Accelerates go/no-go decisions and optimizes resource allocation across synthetic biology portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization of programmable cell system assets.
Implementation Considerations
- Requires expertise in optogenetics, automation programming, and quantitative assay design.
- Depends on integrated instrumentation: illumination device, plate reader, shaker, and robotic arm.
- Demands cross-team standardization of protocols and data formats for reproducibility.
- Adaptation to other model systems may require hardware and protocol modifications.
- Throughput and assay complexity are limited by platform configuration and plate format.
Biopharma FAQs
Why does null hypothesis testing matter for optogenetic response quantification?
Null hypothesis testing enables teams to distinguish true optogenetic effects from background variability in fluorescence and growth measurements, supporting robust target validation and construct selection.
How does independent variable isolation in light stimulation fit the discovery pipeline?
Isolating variables such as light intensity, period, and duty cycle allows systematic evaluation of optogenetic system performance, informing early-stage construct optimization and de-risking.
What do quantitative fluorescence and optical density measurements enable?
These measurements provide real-time, high-throughput data on gene expression and cell growth, enabling direct comparison of optogenetic constructs and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional optogenetic screening?
Replication ensures that observed optogenetic responses are reproducible and reliable, facilitating collaboration between discovery, automation, and analytics teams for portfolio-wide construct evaluation.
What statistical analysis capabilities are required before implementing automated optogenetic assays?
Teams need robust statistical tools to analyze time-resolved fluorescence and growth data, assess significance, and compare responses across multiple constructs and conditions for informed R&D decisions.
